Products

When will the FDA approve Intellia Therapeutics' lonvo-z?

Prediction market on kalshi. If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.

Liquidity: $126.62. Resolves: 1/8/2028.

BLOCKCIRCLE/ONE TERMINAL/150+ VENUES/6 ASSET CLASSES/NON-CUSTODIAL

Sourced. Scored. Routed.

Blockcircle

Quantitative tools and real-time data for crypto and macro markets. Scorecards, trade signals, and research in one platform.

Trade
Whale AlphaPrediction AlphaPolitical AlphaInsider AlphaTrade Alpha
Discover
Momentum Trading EngineAsset Outperformer EngineMarket Reversal EngineAlpha Hunter SuiteMarket Analysis
Scorecards
Global Liquidity ScorecardMacroeconomic Risk ScorecardAltcoin Market Scorecard
Resources
Pulse DashboardEcosystem StatsTrending MarketsUser GuidesInvestment LabsTrading CourseOpen SourceBlog and News
Company
About UsPricingInstitutionalContactTerms & ConditionsPrivacy Policy
© 2026 Blockcircle. All rights reserved.
BUILT FOR THE TRADER·GLOBAL · MULTI-ASSET